AJANTA PHARMA
Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. Established in 1973 and headquartered in Mumbai, Ajanta is committed to ‘Serve Health Care Needs Worldwide’. Ajanta has been consistently providing high quality affordable medicines to patients in different parts of the world. In India, Ajanta Pharma has a significant presence in the fast growing specialty therapeutic segments of cardiovascular, dermatology, ophthalmology and musculoskeletal. With primary focus on new product innovation and introduction, the company has been consistently identifying unmet medical needs and introducing many first-to-market products to cater to those needs.
AUROBINDO PHARMA
Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Through cost effective manufacturing capabilities and a few loyal customers, the company entered the high margin specialty generic formulations segment.
ALEMBIC PHARMACEUTICALS
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic strives to become a knowledge-driven global pharmaceutical company with the highest level of operational excellence in all spheres. Alembic’s mission is to provide access to the best healthcare products at affordable prices to everyone, present anywhere in the world. Alembic Pharmaceuticals Limited understands that only making profit should not be the sole purpose of any enterprise.
ABBOTT INDIA LIMITED
Founded in 1888 by a young Chicago based physician, Dr. Wallace Calvin Abbott, the organization has been devoted to discovering new medicines, new technologies and new ways to manage health. Today, Abbott is a worldwide broad based healthcare company whose products and technologies span the continuum of care – from diagnostics to devices, from nutrition to pharmaceutical therapies. Abbott’s comprehensive line of products encircles life itself – addressing important health needs from infancy to the golden years. Abbott is known for its innovative products and a commitment to applying leading edge science and technologies to advance patient care.
BIOCON LIMITED
Biocon’s ability to continuously scale new heights across the biopharmaceutical value chain enables it to realise the promise of future therapeutics. Kiran Mazumdar-Shaw is Chairperson & Managing Director of Biocon, India’s largest biotech company that is focused on delivering affordable innovation. It is committed to reduce therapy costs of chronic diseases like diabetes, cancer and autoimmune diseases by leveraging India’s cost advantage to deliver affordable healthcare solutions to patients, partners and healthcare systems across the globe. Biocon’s key innovations include an indigenous recombinant human insulin based on proprietary fermentation technology, INSUGEN®, insulin analogue Glargine, BASALOG.
MANKIND PHARMA
Mankind Pharma was founded in 1995 by two brothers, R C Juneja and Rajeev Juneja. The seed capital for establishing the company was Rs.50 lakh. The company was started with 20 employees and now has over 11,000 employees. Mankind’s vast network includes 50 C&F agents and 7500+ stockists providing a wide range of products – Antibiotic, Antifungal, NSAIDs, Gastrointestinal, Anthelmintic, Cardiovascular, Dermal, Erectile Dysfunction, and several other categories – across the nation. Mankind Pharma take great pride in the success of their products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, PregaNews, Adiction, Gas-O-Fast, Kaloree 1, and their latest launch, Heal-O-Kind.
TORRENT PHARMACEUTICALS
Torrent Pharma, the flagship company of Torrent Group, is ranked amongst the top pharma companies of India. It is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. It has also forayed into the therapeutic segments of nephrology and oncology while also strengthening its focus on gynecology and pediatric segments. Right from pioneering niche marketing in India to earning the sobriquet of ‘the company with the most first launches’, Torrent Pharma has always remained ahead of its competition.
SUN PHARMA INDUSTRIES
Sun Pharma is a pharma research and drug discovery company. It was formed in 2007, when India’s leading speciality pharma company, Sun Pharmaceutical Industries Ltd., separated out its active projects in drug discovery and innovation into a new company. This was done in order to bring in the right focus and opportunity for growth for these projects that address international markets. Sun Pharma continues to invest independently in generic research, both for process development for API and formulation development for dosage forms. It is a globally recognised brand and is amongst India’s topmost brands both in terms of recall and recognition, beating many other brands in their industry.
DR. REDDY’S LABORATORIES
Ask any of the 20,000 employees at Dr. Reddy’s why they come to work every day, and you are bound to hear, ‘because Good Health Can’t Wait.’ These simple words describe the deep-rooted belief that drives Dr. Reddy’s. Sometimes the simplest words describe the most profound truths. ‘Good Health’ is the driving goal at Dr. Reddy’s. The company views medicines not just as molecules, but as a means to help patients regain their health. As a leader in the pharmaceutical industry, they realize their unique role and have maintained the highest levels of ethical orientation to ensure good health can be delivered to those who need it.
CIPLA LIMITED
Cipla Limited is an Indian multinational pharmaceutical and biotechnology company, headquartered in Mumbai, India, with presence in Belgium, Surrey in the European Union and Miami, Florida, in the United States; and with manufacturing facilities in Goa (eight), Bengaluru (one), Baddi (one), Indore (one), Kurkumbh (one), Patalganga (one), and Sikkim (one), along with field stations in Delhi, Pune, and Hyderabad. Cipla primarily develops medicines to treat cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions. Cipla’s market capitalisation has been consistently amongst India’s topmost, making it amongst India’s top 50 largest publicly traded companies by market value.
CADILA HEALTHCARE
Cadila Healthcare is an Indian pharmaceutical company headquartered at Ahmedabad in Gujarat. The company is the fifth largest pharmaceutical company in India. It is a significant manufacturer of generic drugs. Cadila was founded in 1952 by Ramanbhai Patel (1952–2001), formerly a lecturer in the L.M. College of Pharmacy, and his business partner Indravadan Modi. It evolved over the next four decades into an established pharmaceutical company. In 1995 the Patel and Modi families split, with the Modi family’s share being moved into a new company called Cadila Pharmaceuticals Ltd. Today, Cadila is a name that is recognised by almost every Indian consumer for both quality and value delivery.
LUPIN
Lupin Pharmaceuticals, Inc. is the wholly owned subsidiary of Lupin Limited, which is among the top five pharmaceutical companies in India. Lupin Pharmaceuticals is dedicated to delivering high-quality, branded and generic medications trusted by healthcare professionals and patients across geographies. Headquartered in Mumbai, India, it is strongly research focused. It has a program for developing new chemical entities. The company has a state-of-the-art R&D center in Pune and is a leading global player in Anti-TB, Cephalosporins (anti-infectives) and Cardiovascular drugs (ACE-inhibitors and cholesterol reducing agents) and has a notable presence in the areas of diabetes, anti-inflammatory and respiratory therapy.
PIRAMAL ENTERPRISES
Piramal Group is a diversified conglomerate with operations in over 30 countries and a strong presence in more than 100 markets around the world. Since the late 1980s, Piramal Group has evolved from a textile-centric business to a diversified organization, which operates across sectors such as health care, life sciences, health care information management, financial services, specialty glass packaging and real estate. As a group, Piramal has consistently identified opportunities ahead of the curve, even when market situations suggest the opposite. The group has invested in the domestic formulations business, at a time when others were focused on growing international generics.
JUBILANT LIFE SCIENCES
Jubilant Life Sciences Limited is an integrated global pharmaceutical and life sciences company engaged in manufacturing and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products, Advance Intermediates, Fine Ingredients, Crop Science Ingredients, Life Science Chemicals and Nutritional Products. The company’s strength lies in its unique offerings of Pharmaceutical and Life Sciences products and services. Jubilant’s success is an outcome of strategic focus on the pharmaceuticals and life sciences industry, moving up the pharmaceutical value chain for products and services across geographies, constantly investing in various growth platforms and promoting a culture of innovation.
RPG LIFE SCIENCES LIMITED
RPG Life Sciences, a part of the Rs. 20,050 crore RPG Enterprises, is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation APIs space. The company is a research based, pharmaceutical company, producing a wide range of quality, affordable medicines. Its brands are highly trusted by healthcare professionals and patients. Customer satisfaction is fundamental to the company. RPG Life Sciences is a forward looking pharmaceutical organization poised for high trajectory growth. With eyes firmly set on the future, RPG Life Sciences is equipped to explore opportunities in the market place to achieve stakeholder delight.
RANBAXY LABORATORIES
Ranbaxy Laboratories Limited is an Indian multinational pharmaceutical company that was incorporated in India in 1961. The company went public in 1973 and Japanese pharmaceutical company Daiichi Sankyo acquired a controlling share in 2008. In 2014, Sun Pharma acquired the entire 63.4% share of Ranbaxy making the conglomerate the world’s fifth largest specialty generic pharma company. As of recent years, Ranbaxy was exporting its products to 125 countries with ground operations in 43 and manufacturing facilities in eight countries. Recently, Ranbaxy Global Consumer Health Care received the OTC Company of the year award.
WOCKHARDT LIMITED
Wockhardt is a global pharmaceutical and biotechnology organisation, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals.Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally. It has 3 research centres and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. Wockhardt is a business in transition. New and innovative business models are in motion to make the most of emerging opportunities.
